Clinical trial
Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of…
NCT00318994 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00318994 |
|---|---|
| Title | Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis |
| Official title | Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pancreatitis |
| Intervention type | Drug |
| Interventions | Meropenem |
| Enrollment | 6 |
| Start date | Feb 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Apr 27, 2006 |
| Last update posted | Sep 1, 2017 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: